These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 10461039)
21. Age-dependent regulation of renal vasopressin V(1A) and V₂ receptors in rats with genetic hypertension: implications for the treatment of hypertension. Burrell LM; Risvanis J; Dean RG; Patel SK; Velkoska E; Johnston CI J Am Soc Hypertens; 2013; 7(1):3-13. PubMed ID: 23246465 [TBL] [Abstract][Full Text] [Related]
22. In vitro and in vivo pharmacological characterisation of the potent and selective vasopressin V(1A) receptor antagonist 4-[4-(4-Chloro-phenyl)-5-[1,2,3]triazol-2-ylmethyl-4H-[1,2,4]triazol-3-yl]-piperidin-1-yl-(3,5-difluoro-phenyl) methanone (PF-00738245). Russell R; Doyle R; Turner J; Attkins N; Ramsey S; Weibley L; Bateman L; Bictash M; Neal-Morgan S; Ivarsson M; Pullen N Eur J Pharmacol; 2011 Nov; 670(2-3):347-55. PubMed ID: 21958878 [TBL] [Abstract][Full Text] [Related]
23. Renal AT1 receptor: autoradiographic localization and quantification in rat. Asano N; Ogura T; Mimura Y; Kishida M; Kataoka H; Otsuka F; Yamauchi T; Makino H Res Commun Mol Pathol Pharmacol; 1998 May; 100(2):161-70. PubMed ID: 9667070 [TBL] [Abstract][Full Text] [Related]
24. The vasopressin receptors colocalize with vasopressin in the magnocellular neurons of the rat supraoptic nucleus and are modulated by water balance. Hurbin A; Orcel H; Alonso G; Moos F; Rabié A Endocrinology; 2002 Feb; 143(2):456-66. PubMed ID: 11796498 [TBL] [Abstract][Full Text] [Related]
25. Vasopressin receptors in rat brain and kidney: studies using a radio-iodinated V1 receptor antagonist. Phillips PA; Kelly JM; Abrahams JM; Grzonka Z; Paxinos G; Mendelsohn FA; Johnston CI J Hypertens Suppl; 1988 Dec; 6(4):S550-3. PubMed ID: 2977179 [TBL] [Abstract][Full Text] [Related]
26. Opioid binding sites in the guinea pig and rat kidney: radioligand homogenate binding and autoradiography. Dissanayake VU; Hughes J; Hunter JC Mol Pharmacol; 1991 Jul; 40(1):93-100. PubMed ID: 1649966 [TBL] [Abstract][Full Text] [Related]
27. Position 4 analogues of [deamino-Cys(1)] arginine vasopressin exhibit striking species differences for human and rat V(2)/V(1b) receptor selectivity. Guillon G; Pena A; Murat B; Derick S; Trueba M; Ventura MA; Szeto HH; Wo N; Stoev S; Cheng LL; Manning M J Pept Sci; 2006 Mar; 12(3):190-8. PubMed ID: 16130178 [TBL] [Abstract][Full Text] [Related]
28. Human kidney as target for somatostatin: high affinity receptors in tubules and vasa recta. Reubi JC; Horisberger U; Studer UE; Waser B; Laissue JA J Clin Endocrinol Metab; 1993 Nov; 77(5):1323-8. PubMed ID: 7915721 [TBL] [Abstract][Full Text] [Related]
29. Pharmacological characterization of RWJ-676070, a dual vasopressin V(1A)/V(2) receptor antagonist. Gunnet JW; Wines P; Xiang M; Rybczynski P; Andrade-Gordon P; de Garavilla L; Parry TJ; Cheung WM; Minor L; Demarest KT; Maryanoff BE; Damiano BP Eur J Pharmacol; 2008 Aug; 590(1-3):333-42. PubMed ID: 18599033 [TBL] [Abstract][Full Text] [Related]
30. Prostaglandin E2 binding sites in human renal tissue: characterization and localization by radioligand binding and autoradiography. Eriksson LO; Larsson B; Hedlund H; Andersson KE Acta Physiol Scand; 1990 Jul; 139(3):393-404. PubMed ID: 2173350 [TBL] [Abstract][Full Text] [Related]
31. Spatial organization of the vascular bundle and the interbundle region: three-dimensional reconstruction at the inner stripe of the outer medulla in the mouse kidney. Ren H; Gu L; Andreasen A; Thomsen JS; Cao L; Christensen EI; Zhai XY Am J Physiol Renal Physiol; 2014 Feb; 306(3):F321-6. PubMed ID: 24305474 [TBL] [Abstract][Full Text] [Related]
32. Effects of YM218, a nonpeptide vasopressin V1A receptor-selective antagonist, on human vasopressin and oxytocin receptors. Tahara A; Tsukada J; Tomura Y; Kusayama T; Wada K; Ishii N; Taniguchi N; Suzuki T; Yatsu T; Uchida W; Shibasaki M Pharmacol Res; 2005 Mar; 51(3):275-81. PubMed ID: 15661579 [TBL] [Abstract][Full Text] [Related]
33. Aquaporin-1 is not expressed in descending thin limbs of short-loop nephrons. Zhai XY; Fenton RA; Andreasen A; Thomsen JS; Christensen EI J Am Soc Nephrol; 2007 Nov; 18(11):2937-44. PubMed ID: 17942963 [TBL] [Abstract][Full Text] [Related]
34. Effects of YM471, a nonpeptide AVP V(1A) and V(2) receptor antagonist, on human AVP receptor subtypes expressed in CHO cells and oxytocin receptors in human uterine smooth muscle cells. Tsukada J; Tahara A; Tomura Y; Wada Ki ; Kusayama T; Ishii N; Yatsu T; Uchida W; Taniguchi N; Tanaka A Br J Pharmacol; 2001 Jul; 133(5):746-54. PubMed ID: 11429400 [TBL] [Abstract][Full Text] [Related]
35. Distribution of vasopressin and oxytocin binding sites in the brain and upper spinal cord of the common marmoset. Schorscher-Petcu A; Dupré A; Tribollet E Neurosci Lett; 2009 Sep; 461(3):217-22. PubMed ID: 19539696 [TBL] [Abstract][Full Text] [Related]
36. Vasopressin V2 receptor expression along rat, mouse, and human renal epithelia with focus on TAL. Mutig K; Paliege A; Kahl T; Jöns T; Müller-Esterl W; Bachmann S Am J Physiol Renal Physiol; 2007 Oct; 293(4):F1166-77. PubMed ID: 17626156 [TBL] [Abstract][Full Text] [Related]
37. Regional distribution of alpha 1-adrenoceptor subtypes in rat kidney. Feng F; Pettinger WA; Abel PW; Jeffries WB J Pharmacol Exp Ther; 1991 Jul; 258(1):263-8. PubMed ID: 1677042 [TBL] [Abstract][Full Text] [Related]
38. Downregulation of vasopressin V2 receptor promoter activity via V1a receptor pathway. Izumi Y; Nakayama Y; Mori T; Miyazaki H; Inoue H; Kohda Y; Inoue T; Nonoguchi H; Tomita K Am J Physiol Renal Physiol; 2007 May; 292(5):F1418-26. PubMed ID: 17213462 [TBL] [Abstract][Full Text] [Related]
39. Localization of vasopressin binding sites in rat tissues using specific V1 and V2 selective ligands. Phillips PA; Abrahams JM; Kelly JM; Mooser V; Trinder D; Johnston CI Endocrinology; 1990 Mar; 126(3):1478-84. PubMed ID: 2307115 [TBL] [Abstract][Full Text] [Related]
40. Design of peptide oxytocin antagonists with strikingly higher affinities and selectivities for the human oxytocin receptor than atosiban. Manning M; Cheng LL; Stoev S; Wo NC; Chan WY; Szeto HH; Durroux T; Mouillac B; Barberis C J Pept Sci; 2005 Oct; 11(10):593-608. PubMed ID: 15880385 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]